Cambridge Healthtech Institute’s 12th Annual

Immunogenicity Case Studies and Clinical Management
( 免疫原性のケーススタディと臨床現場での管理 )

Interpretation and Understanding of Immunogenicity Data in Clinical Settings



As the immunogenicity field is moving forward, closing the gap between clinicians and assay developers is essential in the success of biologic development and accelerates the adoption of new biologic therapies in patient treatments. This year, CHI’s Immunogenicity Case Studies and Clinical Management conference will focus on new case studies of novel biologics and emphasize on closing this gap by providing multiple viewpoints from clinicians, technology developers and regulators on how to use immunogenicity data in clinical settings.


Coverage will include, but is not limited to:


  • New case studies of novel biologics such as cell and gene therapies
  • How clinicians utilize immunogenicity data
  • Preexisting ADA from patients
  • Labeling strategies and interpretation
  • Post marketing commitment
  • Immunotherapy role in immunogenicity management
  • Risk assessment and work flow procedure for clinical outcome prediction
  • Immunogenicity data for patient stratification
  • Strategies for choosing combination therapy in the context of avoiding immunogenicity


* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。

Choose your language
Traditional Chinese
Simplified Chinese